e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Epidemiology of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital
L. Jonathan, Z. Seher, E. Ukeleghe, R. Howell, R. Niven, D. Denning, S. Scott (Chester, Manchester, United Kingdom)
Source:
Annual Congress 2013 –Epidemiology of asthma
Session:
Epidemiology of asthma
Session type:
Thematic Poster Session
Number:
977
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Jonathan, Z. Seher, E. Ukeleghe, R. Howell, R. Niven, D. Denning, S. Scott (Chester, Manchester, United Kingdom). Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital. Eur Respir J 2013; 42: Suppl. 57, 977
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013
Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Detection of pulmonary fungal diseases in patients with fungal rhino-sinusitis
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Bronchopulmonary aspergillosis
Source: Respipedia Article
Year: 2017
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Determinants of non-adherence to pharmacologic allergic rhinitis treatment
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Burden of Allergic Bronchopulmonary Aspergillosis (ABPA) in the India bronchiectasis registry.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Sensitization to moulds in patients with newly diagnosed allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Allergic bronchopulmonary aspergillosis as an occupational disease - special risk in waste management
Source: International Congress 2017 – Case reports and series
Year: 2017
Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014
Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Allergic rhinitis (AR), non allergic rhinitis (NAR) and doctor-diagnosed chronic lung diseases
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept